One aspect of this complexity that is not well understood is the directionality, and possible bidirectionality, of signaling through specific "receptor-ligand" interactions. This question is particularly relevant in the case of two highly important sets of molecular interactions that can function in T cell-B cell communication: the interaction between CD28 on T cells and CD80 (B7.1) and CD86 (B7.2) on B cells, and that between CD40 ligand (CD40L 3 ; CD154) on T cells and CD40 on B cells. Both of these interactions are essential for T-dependent (TD) B cell responses that generate high-affinity, class-switched Ab in vivo (6 -13), but the precise requirement for each interaction in signaling to T cells and/or B cells has not been established under physiologic in vivo conditions.
R egulation of the immune response is marked by complex interactions among the cells that present or recognize Ags. These interactions are mediated in large part by receptor-ligand interactions involving molecules expressed on the surface of participating cells (1, 2) . The activation of T cells for induction of proliferation and effector functions requires both signaling through the Ag-specific TCR and additional signals provided by costimulatory receptors on the T cell (3, 4) . Similarly, the activation of B cells to proliferate and differentiate requires both Ag-specific signaling and additional costimulatory signals (5) . Therefore, interactions between T cells and B cells involve a potentially complex network of signals mediated by communication through multiple receptors expressed by both populations of cells. One aspect of this complexity that is not well understood is the directionality, and possible bidirectionality, of signaling through specific "receptor-ligand" interactions. This question is particularly relevant in the case of two highly important sets of molecular interactions that can function in T cell-B cell communication: the interaction between CD28 on T cells and CD80 (B7.1) and CD86 (B7.2) on B cells, and that between CD40 ligand (CD40L 3 ; CD154) on T cells and CD40 on B cells. Both of these interactions are essential for T-dependent (TD) B cell responses that generate high-affinity, class-switched Ab in vivo (6 -13) , but the precise requirement for each interaction in signaling to T cells and/or B cells has not been established under physiologic in vivo conditions.
The essential role of CD28-CD80/86 interaction is demonstrated by the fact that mice lacking either in CD28 or in both CD80/86 family members are profoundly deficient in the ability to generate in vivo germinal center formation, Ig class switching, memory formation, and affinity maturation through somatic hypermutation (6, 8, 13 ). It has not been established, however, whether these defects reflect a requirement for CD28 signaling of Th cells and/or for CD80/86 signaling of B cells. The ability of CD28 to mediate signaling of T cells has been extensively demonstrated in a number of experimental systems, but evidence has also been reported for signaling of B cells through CD80/86 (14 -17) . Thus, a role for CD80/86 signaling in costimulus-dependent activation of B cells is plausible but has not been directly assessed.
CD40-CD40L interaction is also essential for in vivo TD classswitched Ab responses, and mice lacking in either of these molecules manifest profound deficiencies similar to those observed in CD80/86-or CD28-deficient mice (9, 11, 12) . Extensive evidence has been assembled for the ability of CD40 to transduce signals in B cells and a variety of other cell types (18, 19) . Nevertheless, CD40-deficient B cells can produce class-switched Ab in response to certain T-independent Ag (20) , demonstrating that induction of the class-switch machinery can occur without CD40 signaling. In addition, data indicating that CD40L can signal directly to T cells has been reported (21) (22) (23) . Thus, it is again unclear whether signaling of T cells and/or of B cells explains the requirement for CD40-CD40L participation in TD B cell immune responses.
The experiments described here address the nature of the requirements for CD80/86-and CD40-dependent costimulation in TD IgG and IgE responses to in vivo antigenic challenge. The results demonstrate that the need for these two molecules is different. In a mixed bone marrow chimera environment only B cells that express CD40 are capable of responding, indicating a strict requirement for CD40 expression and potentially for CD40 signaling in in vivo TD B cell activation. In marked contrast, both wild-type (WT) B cells and CD80/86-deficient B cells respond efficiently in chimeric animals, indicating that although CD80/86 plays a critical role in these responses, direct CD80/86 signaling of a B cell is not essential for its efficient activation. 
Materials and Methods

Mice
Purification and in vitro activation of B cells
Enriched populations of splenic B cells were obtained using magnetic CD19 beads according to the manufacturer's instructions (Miltenyi Biotec, Auburn, CA). Cells (2 ϫ 10 5 ) were cultured in 24-well flat-bottom plates in 1 ml of complete medium consisting of RPMI 1640 (BioWhittaker, Walkersville, MD) supplemented with 10% FCS (Biofluids, Rockville, MD), sodium pyruvate (1%), nonessential amino acids (1%), L-glutamine (0.5%), 2-ME (5 ϫ 10 Ϫ5 M), penicillin (100 U/ml), and streptomycin (100 g/ml) and incubated at 37°C in a humidified atmosphere containing 5% CO 2 . To induce specific isotype switching, B cells were stimulated either with 15 g/ml LPS (Difco, Detroit, MI) and 1000 U/ml recombinant mouse IL-4 (prepared from a baculovirus expression system in our laboratory) or with 2.15 g/ml mouse membrane CD40L (kindly provided by Dr. M. Kehry, IDEC Pharmaceuticals, San Diego, CA) and 1000 U/ml IL-4. Supernatants were harvested on day 6 for quantitation of Ig by ELISA.
Flow cytometric analysis
Single-cell suspensions were prepared from peripheral blood and spleen, and erythrocytes removed by treatment with ACK lysing buffer (Biofluids 
In vivo immunization
Mice were immunized i.p. with 100 g trinitrophenyl-keyhole limpet hemocyanin (TNP-KLH) in Imject alum (Pierce, Rockford, IL), and serum was collected on day 0 before immunization and days 7, 14, and 21 after immunization. Mice were boosted in the same manner on day 27 or 28, and serum was collected on days 4, 8, and 12 after rechallenge.
Ig detection by ELISA
Total IgG1, IgM, or IgE was captured with purified goat anti-mouse IgG1, IgM, or IgE (Southern Biotechnology Associates, Birmingham, AL) and detected with HRP-conjugated goat anti-mouse ␥1, (Southern Biotechnology Associates) or with biotinylated rat anti-mouse IgE (BD PharMingen) and HRP-conjugated streptavidin (Southern Biotechnology Associates). To measure Ag-specific IgG1 or IgM, plates were coated with 2.5 g per well trinitrophenyl-keyhole limpet hemocyanin-OVA, and Ig was detected with HRP-conjugated goat anti-mouse ␥1 or . Allotype-specific IgG1 and IgM were measured using biotinylated anti-mouse and detected with biotinylated rat anti-mouse IgE (BD PharMingen) and HRP-conjugated streptavidin. Reagent specificity was confirmed by analysis of serum from immunized B6.Igh a and B6.Igh b mice. In all cases, wells were developed with ABTS Microwell Peroxidase Substrate System FIGURE 1. Impaired IgG1 and IgE production in CD80/86-and CD40-deficient mice. WT, CD80/86 KO, and CD40 KO mice (4 -5 per group) were immunized with TNP-KLH/alum on days 0 and 27 (as shown by arrows), and serum was collected at the indicated time points. Serum levels of Ag-specific IgG1 and IgM as well as total IgE were assayed by ELISA. Data points represent the geometric mean Ϯ geometric SEM of the ELISA titers.
(Kirkegaard & Perry Laboratories, Gaithersburg, MD), and OD was measured at 405 nm. Titers were determined by interpolation of the dilution that gave a 50% OD of the maximum absorbance achieved.
Chimeras
Radiation bone marrow chimeras were prepared as described previously (24 
Results
Impaired IgG1 and IgE production in CD40-and CD80/86-deficient mice
A lack of CD80/86 or CD40 has been shown to profoundly reduce the Ab response to TD Ags in vivo, impairing germinal center formation, Ig class switching, memory formation, and affinity maturation through Ig hypermutation (9, 13) . The need for CD80/86 and for CD40 was assessed here by immunizing WT, CD80/86 KO, and CD40 KO mice with the TD Ag TNP-KLH in alum adjuvant; boosting with the same Ag adjuvant at day 27 after the primary immunization; and measuring Ab levels at successive time points as indicated (Fig. 1) . WT mice generated a robust Ag-specific primary response and a faster, amplified secondary response. There was no difference in Ag-specific IgM titers between CD80/86 or CD40 KO and WT animals, consistent with previous demonstrations that an unswitched IgM response can be generated in the absence of costimulatory molecules (8, 9, (11) (12) (13) . In contrast, the Ag-specific IgG1 response was completely nullified in both CD80/86 KO and CD40 KO mice, even after a secondary immunization. Because it was not possible to measure Ag-specific IgE in response to immunization (data not shown), we measured total IgE serum levels. Levels of total IgE were low or undetectable in unimmunized mice but increased significantly after immunization of WT mice (Fig. 1) . But unlike the controls, CD80/86 and CD40 KO mice were unable to generate an IgE response. These results are consistent with the conclusions of previous reports (6 -13) and demonstrate the need for both the CD40-CD40L and CD80/86-CD28 pathways in generating Ig class-switched primary and secondary Ab responses to TD Ags.
CD80/86-and CD40-deficient B cells do not have an intrinsic inability to make IgG1 and IgE
It was important to test the possibility that B cells maturing in the absence of CD80/86 or CD40 may have an intrinsic inability to make IgG1 or IgE. CD19
ϩ splenic B cells were purified from WT, CD80/86 KO, and CD40 KO mice and cultured in vitro with the polyclonal activators LPS or mCD40L, plus IL-4 to facilitate class switching. Levels of IgG1, IgE, and IgM were measured in day 6 culture supernatants. There was no difference between CD80/86 KO and WT B cell responses to LPS (Fig. 2) or mCD40L (data not shown). As expected, CD40 KO cells did not respond to mCD40L (data not shown); however, responses to LPS were equivalent to those of WT B cells (Fig. 2) . Thus, the observed in vivo deficiencies in the responses of CD80/86 KO and CD40 KO mice are not due to an inherent inability of their B cells to undergo activation and class switching to IgG1 and IgE as measured in vitro.
CD80/86 KO, but not CD40 KO, B cells participate in humoral immune responses in the presence of WT bone marrow-derived cells
Although previous studies have demonstrated that CD40-CD40L and CD80/86-CD28 costimulatory pathways are required for in vivo TD B cell responses, the mechanism mediating this requirement is not well established. To determine whether CD80/86 and CD40 are involved in the delivery of T cell signals directly to B cells, we developed a radiation bone marrow chimera strategy. The objective was to create a situation in which both WT and KO B cells matured and differentiated in the same mouse. CD80/86 WT/ CD80/86 KO and CD40 WT/CD40 KO chimeric mice were generated in which WT (Igh a )-and KO (Igh b )-derived B cells and Ig could be distinguished by allotype-specific reagents. Control chimeras were also generated in which irradiated WT mice were reconstituted with equal numbers of bone marrow cells from congenic WT Igh a and WT Igh b mice. Mice were then immunized with TNP-KLH/alum, and Ab titers were measured at various time points using allotype-specific assays. The responses of control chimeras were analyzed first to determine whether Igh a and Igh b production by WT cells could be detected in a chimeric environment (Fig. 3) (Fig. 4) 
Discussion
The present studies were designed to define the roles of CD80/86 and CD40 in B cell activation. Our goal was to establish whether cell-autonomous expression of CD80/86 and CD40 on B cells is required for B cell activation and Ig secretion in the context of a TD humoral immune response. Previous studies, as well as the experiments described in this study, demonstrated that CD80/86-CD28 and CD40-CD40L interactions are needed during TD B cell responses (6 -12, 25, 26) . However, it has been difficult in vivo to dissociate defects in T cell help from defects in B cell activation when either the CD80/86-CD28 or CD40-CD40L pathways have been disrupted. To address this issue, we created mixed chimeras in which CD80/86-or CD40-deficient B cells coexist with WT cells, thereby restoring an environment that is fully competent to support T cell-and costimulus-dependent B cell responses to Ag. Allotype-specific reagents were then used to determine whether CD80/86-or CD40-deficient bone marrow-derived cells were able to secrete levels of Ag-specific Ig comparable to the WT B cells in (Fig. 6) .
Our findings in the CD80/86 WT/CD80/86 KO mixed chimera indicated that direct CD80/86 signaling is not essential for B cell activation. Recent studies, however, have suggested that CD80/86 signaling can occur in B cells and can enhance the B cell immune response. Ligation of CD86 on human tonsillar cells (15) or on mouse TNP-specific B cells (16) has been shown to result in a modest increase in IgE and IgG4/IgG1 production, while crosslinking of CD86 on LPS-stimulated mouse B cells enhanced proliferation and production of IgG1 and IgG2a (17) . Furthermore, cross-linking of CD80 on human B cell lines can induce protein phosphorylation, growth arrest, and morphological changes (14) . While our findings do not preclude the possibility that direct signaling to B cells via CD80/86 may play a role under certain conditions, the CD80/86 WT/CD80/86 KO mixed chimera studies reported in this study demonstrate that CD80/86 signaling in B cells is not required for Ab production, Ig class switching, or memory B cell responses in a model of physiologic in vivo response to antigenic challenge. CD40 is known to signal directly to cells on which it is expressed, and much about the mechanisms coupling CD40 to intracellular signaling pathways has been described (19, 27) . Transgenic mice that express mutants of CD40 unable to associate with TNFR-associated factors, the adaptor molecules that couple CD40 to downstream kinases, are defective in Ab responses to TD Ags, illustrating the importance of CD40 signaling in these responses (28, 29) . However, the requirement for CD40 expression by B cells participating in TD responses has not previously been characterized. The studies reported in this paper were designed to determine whether expression of CD40 by a B cell is essential for the ability of that B cell to respond in vivo, or whether CD40-dependent interactions in the immune environment can function in trans to support responses of CD40 KO B cells. Our CD40 WT/CD40 KO mixed chimeras allowed us to address this issue and demonstrated that CD40 must be expressed on B cells responding to TD antigenic challenge; expression in trans cannot rescue the response of CD40 KO B cells.
The need for cell-autonomous expression of CD40 on B cells responding to TD Ags most likely reflects a requirement for direct CD40 signaling to the B cell. CD40 signaling in B cells promotes a number of downstream effects, including up-regulation of cell surface molecules such as ICAM-1 (30), CD80/86 (31-33), and MHC class II (34); survival in germinal centers; and isotype switching. Any or all of these downstream effects of CD40 signaling may explain the necessity for cell-autonomous expression of CD40. But we cannot exclude the possibility that cell-autonomous expression of CD40 may play a role in increasing the affinity of cognate interactions with CD40L-expressing T cells, a role that would not necessarily require CD40 signaling.
Our finding that CD40 expression on B cells is necessary for B cell responses runs counter to a recent study (35) in which use of an agonistic Ab to CD28 was able to restore a Th2-dependent B cell response to an adenovirus vector in CD40L KO mice. The authors of this study concluded that direct CD40 signaling to B cells during a Th2-TD response is not required if Th cell function is activated. It is possible that the cross-linking of CD28 with agonistic anti-CD28 Ab may have distinctly different effects than ligation of CD28 by its natural ligand, CD80/86, in the course of physiologic cell interactions in vivo.
Although mice deficient in either the CD80/86-CD28 or CD40-CD40L costimulatory pathways display similar defects in response to challenge with TD Ags, we conclude that these pathways play very different roles in TD immune responses. Expression of CD80/86 molecules on responding B cells is not required, suggesting that the primary role of CD80/86 during TD responses is to facilitate events, such as the activation of T cells, that are necessary to drive the humoral response. In contrast, cell-autonomous expression of CD40 is required for B cell activation, indicating that ligation of CD40 on B cells elicits signals that are essential to the production of class-switched Ab in response to challenge with TD Ags and that cannot be provided by CD40 expressed on other cells in the immune environment. 
